Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T‐cell lymphoma in a Chinese population: A multicenter phase II trial

Angioimmunoblastic T‐cell lymphoma (AITL) is a common type of peripheral T‐cell lymphoma (PTCL) with a poor prognosis, and an effective first‐line therapy is lacking. Chidamide is a selective histone deacetylase inhibitor and has been approved by the China Food and Drug Administration for relapsed o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yawen, Zhang, Mingzhi, Song, Wei, Cai, Qingqing, Zhang, Liling, Sun, Xiuhua, Zou, Liqun, Zhang, Huilai, Wang, Lili, Xue, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314976/
https://www.ncbi.nlm.nih.gov/pubmed/35170082
http://dx.doi.org/10.1002/ajh.26499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314976/
https://www.ncbi.nlm.nih.gov/pubmed/35170082
http://dx.doi.org/10.1002/ajh.26499

Ejemplares similares